Transcendental Meditation (TM) to reduce stress and improve immunity of health care providers during COVID-19 pandemic
- Registration Number
- CTRI/2020/09/027910
- Lead Sponsor
- All India Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
1. Any healthcare provider including doctors, nurses, and other healthcare staff involved in COVID-19 patient care at All India Institute of Medical Sciences is eligible for the study.
2. Agreement to attending the 5-day session for learning TM and dedicating 40 mins per day for practice TM at home/workplace
1. Healthcare provider with a history of autoimmune disorders/compromised immunity/trauma related issues/complicated diabetes/renal disorders/etc.
2. Those with any form of recreational drug use within the past 15 days from learning TM, are not eligible to learn TM and thus will be excluded from this study or will be taught at a later time.
3. Any individual who has learnt TM in the past.
4. Any individual currently practicing any other form of meditation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Perceived stress, measured using Perceived stress scale (PSS)Timepoint: Baseline and at one, two and three months post intervention
- Secondary Outcome Measures
Name Time Method Immune cell counts: CD3 will be used to identify T-cells, CD4 for helper T-cells, CD8 for cytotoxic T-cells, CD20 for B-cells, CD16 and CD56 for natural killer (NK) cells. Plasma cells expression will also be evaluated <br/ ><br>Timepoint: Baseline and at one and three months post intervention;Inflammatory Cytokines (Il-6,8,10, and tumor necrosis factor (TNF)-αTimepoint: Baseline and at one and three months post intrvention;Salivary cortisol and salivary amylase, Serum Cortisol and Beta-Endorphins levels.Timepoint: Baseline and at one and three months post intervention;Self-perceived immune status <br/ ><br>Health related quality of life will be assessed by Short Form-36 <br/ ><br>Timepoint: Baseline and at one, two and three months post intervention